• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国酒精相关性肝病的发病和管理模式:一项全国性标准队列研究。

Incidence and management patterns of alcohol-related liver disease in Korea: a nationwide standard cohort study.

机构信息

Division of Gastroenterology, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, 892 Dongnam-ro, Gangdong-gu, Seoul, 05278, Korea.

Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, Seoul, Korea.

出版信息

Sci Rep. 2021 Mar 23;11(1):6648. doi: 10.1038/s41598-021-86197-z.

DOI:10.1038/s41598-021-86197-z
PMID:33758281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7987970/
Abstract

The recent incidence and management patterns of alcohol-related liver disease (ARLD) are not well defined in Korea. We sought to evaluate the epidemiology of ARLD with regard to disease severity and alcohol cessation management after diagnosis. We performed an observational cohort study of standardized Common Data Model data from the Health Insurance Review and Assessment-National Patient Samples database between 2012 and 2016. The incidence and demographic properties of ARLD were extracted and divided into non-cirrhotic alcoholic liver disease (ALD) and alcoholic liver cirrhosis (ALC). ALC was compared with non-alcoholic cirrhosis by severity at diagnosis. The management patterns were captured by the initiation of pharmaco- and behavioral therapy for alcohol cessation. We analyzed data from 72,556 ALD to 7295 ALC patients. The ALD incidence was stable from 990 to 1025 per 100,000 people. In ALD, the proportion of patients who were ≥ 65 years old, the proportion of female patients, and the comorbidity index increased significantly during the study period (all P values < 0.001). ALC accounted for > 20% of all cirrhosis, with decompensation occurring twice as often as in non-alcoholic cirrhosis. The initiation of alcoholism management was stationary in ARLD, remaining at < 10% for both pharmacotherapy and behavioral therapy, regardless of severity or the site of diagnosis. The incidence of ARLD did not decrease during the study period. Moreover, an increasing trend in the proportion of people vulnerable to drinking was observed. Unfortunately, management for the cessation of alcohol use remains very low. The best way to manage ARLD should be evaluated in further study.

摘要

韩国目前尚不清楚与酒精相关的肝病(ARLD)的发病率和管理模式。我们旨在评估 ARLD 的流行病学,包括疾病严重程度和确诊后的酒精戒断管理。我们对 2012 年至 2016 年间健康保险审查和评估-国家患者样本数据库中的标准化通用数据模型数据进行了观察性队列研究。提取了 ARLD 的发病率和人口统计学特征,并将其分为非肝硬化性酒精性肝病(ALD)和酒精性肝硬变(ALC)。根据诊断时的严重程度,将 ALC 与非酒精性肝硬化进行比较。通过开始药物和行为治疗以戒除酒精来捕获管理模式。我们分析了 72556 例 ALD 和 7295 例 ALC 患者的数据。ALD 的发病率从 990 人至 1025 人/100000 人保持稳定。在 ALD 中,≥65 岁患者的比例、女性患者的比例和合并症指数在研究期间显著增加(所有 P 值均<0.001)。ALC 占所有肝硬化的比例超过 20%,且失代偿的发生频率是非酒精性肝硬化的两倍。ARLD 的戒酒管理保持静止,药物治疗和行为治疗的启动率均<10%,无论严重程度或诊断部位如何。在研究期间,ARLD 的发病率没有下降。此外,观察到易饮酒人群的比例呈上升趋势。不幸的是,戒酒管理仍然非常低。应在进一步的研究中评估管理 ARLD 的最佳方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd26/7987970/b01f8eef6783/41598_2021_86197_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd26/7987970/fba1f879b420/41598_2021_86197_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd26/7987970/34f6eb3681f6/41598_2021_86197_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd26/7987970/7e9505f2a64c/41598_2021_86197_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd26/7987970/66a82cc40ca3/41598_2021_86197_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd26/7987970/b01f8eef6783/41598_2021_86197_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd26/7987970/fba1f879b420/41598_2021_86197_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd26/7987970/34f6eb3681f6/41598_2021_86197_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd26/7987970/7e9505f2a64c/41598_2021_86197_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd26/7987970/66a82cc40ca3/41598_2021_86197_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd26/7987970/b01f8eef6783/41598_2021_86197_Fig5_HTML.jpg

相似文献

1
Incidence and management patterns of alcohol-related liver disease in Korea: a nationwide standard cohort study.韩国酒精相关性肝病的发病和管理模式:一项全国性标准队列研究。
Sci Rep. 2021 Mar 23;11(1):6648. doi: 10.1038/s41598-021-86197-z.
2
Trends in alcohol use and alcoholic liver disease in South Korea: a nationwide cohort study.韩国饮酒和酒精性肝病趋势:一项全国性队列研究。
BMC Public Health. 2024 Jul 10;24(1):1841. doi: 10.1186/s12889-024-19321-z.
3
Disease spectrum of alcoholic liver disease in Beijing 302 Hospital from 2002 to 2013: A large tertiary referral hospital experience from 7422 patients.2002年至2013年北京302医院酒精性肝病的疾病谱:来自一家大型三级转诊医院7422例患者的经验
Medicine (Baltimore). 2017 Feb;96(7):e6163. doi: 10.1097/MD.0000000000006163.
4
Current Status of Alcoholic Liver Disease in Japan and Therapeutic Strategy.日本酒精性肝病的现状与治疗策略
Nihon Arukoru Yakubutsu Igakkai Zasshi. 2016 Aug;51(2):71-90.
5
The impact of alcohol care teams on emergency secondary care use following a diagnosis of alcoholic liver disease - a national cohort study.酒精护理团队对酒精性肝病诊断后急诊二级护理使用的影响——一项全国队列研究。
BMC Public Health. 2016 Aug 2;16:685. doi: 10.1186/s12889-016-3350-0.
6
Alcoholic liver disease: A registry view on comorbidities and disease prediction.酒精性肝病:基于登记数据的合并症及疾病预测观察。
PLoS Comput Biol. 2020 Sep 22;16(9):e1008244. doi: 10.1371/journal.pcbi.1008244. eCollection 2020 Sep.
7
Impacts of smoking on alcoholic liver disease: a nationwide cohort study.吸烟对酒精性肝病的影响:一项全国性队列研究。
Front Public Health. 2024 Aug 7;12:1427131. doi: 10.3389/fpubh.2024.1427131. eCollection 2024.
8
National survey of alcoholic liver disease in Japan (1968-91).日本酒精性肝病全国调查(1968 - 1991年)
J Gastroenterol Hepatol. 1995 Sep-Oct;10(5):509-16. doi: 10.1111/j.1440-1746.1995.tb01339.x.
9
The natural history of alcohol-related liver disease.酒精性肝病的自然史。
Curr Opin Gastroenterol. 2020 May;36(3):164-168. doi: 10.1097/MOG.0000000000000627.
10
Development of severe alcohol related liver disease over four decades in Iceland: impact of increased access and use of alcohol.冰岛四十年来严重酒精相关性肝病的发展:酒精获取和使用增加的影响
Scand J Gastroenterol. 2023 Jul-Dec;58(12):1523-1533. doi: 10.1080/00365521.2023.2245939. Epub 2023 Aug 8.

引用本文的文献

1
Impact of metabolic risk factors on hepatic and cardiac outcomes in patients with alcohol- and non-alcohol-related fatty liver disease.代谢风险因素对酒精性和非酒精性脂肪性肝病患者肝脏和心脏结局的影响。
JHEP Rep. 2023 Mar 5;5(6):100721. doi: 10.1016/j.jhepr.2023.100721. eCollection 2023 Jun.
2
Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions.肝硬化及其相关并发症的流行病学:当前知识和未来方向。
World J Gastroenterol. 2022 Nov 7;28(41):5910-5930. doi: 10.3748/wjg.v28.i41.5910.

本文引用的文献

1
Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.亚太地区的肝脏疾病:《柳叶刀·胃肠病学和肝脏病学》专刊。
Lancet Gastroenterol Hepatol. 2020 Feb;5(2):167-228. doi: 10.1016/S2468-1253(19)30342-5. Epub 2019 Dec 15.
2
Impact of Alcohol Use Disorder Treatment on Clinical Outcomes Among Patients With Cirrhosis.酒精使用障碍治疗对肝硬化患者临床结局的影响。
Hepatology. 2020 Jun;71(6):2080-2092. doi: 10.1002/hep.31042. Epub 2020 May 22.
3
Trends in the prevalence of chronic liver disease in the Korean adult population, 1998-2017.
1998 - 2017年韩国成年人群慢性肝病患病率趋势
Clin Mol Hepatol. 2020 Apr;26(2):209-215. doi: 10.3350/cmh.2019.0065. Epub 2019 Nov 4.
4
Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases.酒精性肝病的诊断与治疗:美国肝病研究协会2019年实践指南
Hepatology. 2020 Jan;71(1):306-333. doi: 10.1002/hep.30866.
5
Trends in Characteristics, Mortality, and Other Outcomes of Patients With Newly Diagnosed Cirrhosis.新诊断肝硬化患者的特征、死亡率和其他结局的变化趋势。
JAMA Netw Open. 2019 Jun 5;2(6):e196412. doi: 10.1001/jamanetworkopen.2019.6412.
6
Prevalence of Alcoholic Fatty Liver Disease Among Adults in the United States, 2001-2016.美国成年人酒精性脂肪肝疾病的患病率,2001-2016 年。
JAMA. 2019 May 7;321(17):1723-1725. doi: 10.1001/jama.2019.2276.
7
Treating alcohol-related liver disease from a public health perspective.从公共卫生角度治疗酒精相关肝病。
J Hepatol. 2019 Feb;70(2):223-236. doi: 10.1016/j.jhep.2018.10.036.
8
Alcohol-related liver disease: Time for action.酒精性肝病:行动时刻。
J Hepatol. 2019 Feb;70(2):221-222. doi: 10.1016/j.jhep.2018.12.007.
9
Grand Rounds: Alcoholic Hepatitis.大查房:酒精性肝炎。
J Hepatol. 2018 Aug;69(2):534-543. doi: 10.1016/j.jhep.2018.05.001. Epub 2018 Jun 13.
10
Course of remission from and relapse to heavy drinking following outpatient treatment of alcohol use disorder.酒精使用障碍门诊治疗后缓解和复发至重度饮酒的过程。
Drug Alcohol Depend. 2018 Jun 1;187:319-326. doi: 10.1016/j.drugalcdep.2018.03.011. Epub 2018 Apr 16.